Citius Oncology, Inc. Common Stock (CTOR) is a publicly traded Healthcare sector company. As of May 21, 2026, CTOR trades at $0.83 with a market cap of $77.07M and a P/E ratio of -2.37. CTOR moved -4.61% today. Year to date, CTOR is -28.17%; over the trailing twelve months it is -7.19%. Its 52-week range spans $0.49 to $6.19. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces CTOR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Citius Oncology, Inc. Common Stock (CTOR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CTOR moved -4.61% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.83 |
| Market Cap | $77.07M |
| P/E Ratio | -2.37 |
| EPS | $-0.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.19 |
| 52-Week Low | $0.49 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-24.76M |
| Gross Margin | 0.00% |
1 analysts cover CTOR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.